Publications by authors named "Steven Sands"

Claim this Profile
N
Novel benzamide-based histamine h3 receptor antagonists: the identification of two candidates for clinical development.
Michael A Letavic, Leah Aluisio, Richard Apodaca, Manoj Bajpai, Ann J Barbier, Steven B Sands

ACS Med Chem Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staged treatment of high energy midfoot fracture dislocations.
Tiffany R Kadow, Peter A Siska, Andrew R Evans, Steven S Sands, Ivan S Tarkin

Foot Ankle Int· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convergent and divergent dislocation of the pediatric elbow: two case reports and comprehensive review of literature.
Shital N Parikh, Marios G Lykissas, Charles T Mehlman, Steven Sands, Jose Herrera-Soto

J Pediatr Orthop B· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [¹¹C]GSK189254 in anesthetized baboon.
Jean Logan, Nicholas I Carruthers, Michael A Letavic, Steven Sands, Xiaohui Jiang

Psychopharmacology (Berl)· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.
Christopher J O'Donnell, Bruce N Rogers, Brian S Bronk, Dianne K Bryce, Jotham W Coe, Steven B Sands

J Med Chem· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists.
Christopher J O'Donnell, Langu Peng, Brian T O'Neill, Eric P Arnold, Robert J Mather, Steven B Sands

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological effects of nicotine on norepinephrine metabolism in rat brown adipose tissue: relevance to nicotinic therapies for smoking cessation.
Dominique J Brees, Michael R Elwell, F David Tingley, Steven B Sands, Amy B Jakowski

Toxicol Pathol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.
Donn G Wishka, Daniel P Walker, Karen M Yates, Steven C Reitz, Shaojuan Jia, Steven B Sands

J Med Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation.
Jotham W Coe, Paige R Brooks, Michael C Wirtz, Crystal G Bashore, Krista E Bianco, Steven B Sands

Bioorg Med Chem Lett· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
Jotham W Coe, Michael G Vetelino, Crystal G Bashore, Michael C Wirtz, Paige R Brooks, Steven B Sands

Bioorg Med Chem Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
Jotham W Coe, Paige R Brooks, Michael G Vetelino, Michael C Wirtz, Eric P Arnold, Steven B Sands

J Med Chem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
Leslie C Newman, Steven S Sands, David R Wallace, Craig W Stevens

J Pharmacol Exp Ther· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis